share_log

B. Riley Securities Upgrades Vaxart to Buy, Announces $2 Price Target

Benzinga ·  Jan 31 22:48

B. Riley Securities analyst Mayank Mamtani upgrades Vaxart (NASDAQ:VXRT) from Neutral to Buy and announces $2 price target.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment